
|Articles|August 16, 2019
Improving the Economic Burden of Ankylosing Spondylitis: Targeting IL-17/IL-23 Pathways
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement















































